Munjot Sahu

Munjot Sahu

Faegre Drinker Biddle & Reath LLP

Contact
View Bio
RSS

Latest Posts › Generic Drugs

Share:

What's in a Name? A Four-Letter Suffix to Be FDA Compliant

The BPCIA and the Debate Over Naming Biosimilars - Most drugs on the market today are small-molecule compounds with active pharmaceutical ingredients that can be duplicated to create “generic” drugs. It is impossible,...more

1/19/2017  /  Biosimilars , BPCIA , Food and Drug Administration (FDA) , Generic Drugs , Pharmaceutical Industry
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide